prucalopride: Clinical Trials

66 trials of prucalopride, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

48 completed, 7 unknown, 3 not yet recruiting, 3 recruiting. 22 Phase 3, 14 Phase 2, 12 Phase 1, 11 Phase 4, 8 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 322Completed 17, Terminated 2, Unknown 2, Recruiting 1
Phase 214Completed 12, Unknown 2
Phase 112Completed 12
Phase 411Completed 5, Unknown 4, Recruiting 1, Terminated 1
Not applicable8Completed 5, Not yet recruiting 2, Recruiting 1
Early Phase 11Not yet recruiting 1

Follow prucalopride: new trials by email Literature Review of prucalopride trials Research Report on prucalopride

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prucalopride for Cognitive Functioning in Schizophrenia
Prucalopride 1 MG - Schizophrenia
Not applicableNot yet recruitingUniversity of Pittsburgh342027-05-312026-09-17
PROMOTE: Effects of 5-HT4 Agonism on Cognition and Sleep in Peopl With Low Mood
Prucalopride, Placebo Comparator - Low Mood, Depression - Major Depressive Disorder
Not applicableNot yet recruitingUniversity of Oxford602026-10-012026-10-06
Prucaloprida vs Bisacodyl as a Stimulant in Bowel Preparation for Video Colonoscopy in Adults
Bisacodyl 5 MG, Prucalopride 2mg - Bowel Preparation
Early Phase 1Not yet recruitingHospital de Clínicas Dr. Manuel Quintela1242025-09-012025-08-17
Impact of Varying Doses of Prucalopride on Improving Gut Function Recovery After Elective Colorectal Surgery
Prucalopride 2mg, Prucalopride 4mg, Standard Care - Post-Op Complication
Phase 3RecruitingFuture University in Egypt1802025-03-022025-03-19
Gastrointestinal Dysmotility on Aspiration Risk
Prucalopride, Famotidine - Esophageal Motility Disorders, Gastric Motor Dysfunction
Phase 4RecruitingBoston Children's Hospital1202025-02-132026-08-03
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
FLIP, HRM, Prucalopride - Dysphagia, Achalasia, Esophageal
Not applicableRecruitingNorthwestern University5752024-09-012026-09-23
Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure
polyethylene glycol, sodium phosphate, polyethylene glycol + ascorbic acid - Colon Cancer, Inflammatory Bowel Diseases
Phase 3CompletedRegion Skane1472023-02-012024-02-28
The Effect of Prucalopride on Gastric Emptying in Intensive Care Unit Patients
Prucalopride, Metoclopramide - Enteral Feeding Intolerance
Phase 1 / Phase 2CompletedAin Shams University702022-08-302024-04-12
Preventing Gastric Glitch With Prucalopride and Buspirone: N-of-1 Clinical Trial
Prucalopride, Buspirone, Placebo - Dyspepsia
Phase 1 / Phase 2CompletedUniversidade de Passo Fundo12022-01-062022-05-17
Prucalopride and Cognition in Recovered Depression
Prucalopride, Placebo - Depression in Remission
Not applicableCompletedUniversity of Oxford502022-01-042024-02-09
Prucalopride for Postoperative Ileus in Patients Undergoing Robot-assisted Laparoscopic Radical Cystectomy
Prucalopride, Placebo - Postoperative Ileus, Bladder Cancer
Phase 2UnknownThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1602021-09-012021-08-12
Study of Comparative Effectiveness of Prucalopride and Lubiprostone in Constipation Predominant Irritable Bowel Syndrome
Prucalopride 2mg - Patient Satisfaction
Phase 4UnknownBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1402021-08-152021-08-30
A Study of Prucalopride For Functional Constipation in Children and Teenagers
Prucalopride, Placebo - Constipation
Phase 3TerminatedTakeda1752021-07-132024-06-06
The Effects of Prucalopride in Patients With Constipation Predominant Irritable Bowel Syndrome
Prucalopride 2mg - Irritable Bowel Syndrome
Phase 2 / Phase 3UnknownBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1602021-03-102021-10-22
Prucalopride Treatment for Refractory Gastro-esophageal Reflux Disease
Prucalopride, Placebo Oral Tablet - GERD
Phase 4UnknownUniversitaire Ziekenhuizen KU Leuven602019-02-182019-12-05
Effects of Seven Day Prucalopride Administration in Healthy Volunteers
Prucalopride, Placebo - Molecular Mechanisms of Pharmacological Action, Depression
Not applicableCompletedUniversity of Oxford502018-06-112022-11-18
Prucalopride in Postoperative Ileus
Prucalopride, Placebo Oral Capsule - Postoperative Ileus, Colorectal Surgery
Phase 3CompletedUniversity of Auckland, New Zealand1502017-10-252021-09-29
Treatment of Dysphagia and Ineffective Esophageal Motility With Prucalopride: A Pilot Study
Prucalopride - Ineffective Esophageal Motility, Dysphagia
Phase 2CompletedUniversity of Calgary282017-10-202020-03-25
Efficacy of PRUcalopride in Critically Ill Patients With Paralytic ILeus
Prucalopride, Placebo - Paralytic Ileus, Critically Ill
Phase 3UnknownPrince of Songkla University622017-07-012020-02-06
Effects of Acute Prucalopride Administration in Healthy Volunteers
Prucalopride, Placebo - Molecular Mechanisms of Pharmacological Action, Depression
Not applicableCompletedUniversity of Oxford412017-02-072019-03-05

Showing 20 of 66. Sign in to see all of them.

Conditions studied

Constipation (27)  ·  Depression (3)  ·  Deglutition Disorders (2)  ·  Depressive Disorder (2)  ·  Dyspepsia (2)  ·  Gastroesophageal Reflux (2)  ·  Gastrointestinal Hemorrhage (2)  ·  Gastroparesis (2)  ·  Inflammatory Bowel Diseases (2)  ·  Mental Disorders (2)  ·  Mood Disorders (2)  ·  Postoperative Complications (2)  ·  Celiac Disease (1)  ·  Cognition Disorders (1)  ·  Colonic Neoplasms (1)

Sponsors

Movetis (22)  ·  Shire (5)  ·  Universitaire Ziekenhuizen KU Leuven (4)  ·  University of Oxford (4)  ·  Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (2)  ·  Queen's University (2)  ·  University of Calgary (2)  ·  Yuhan Corporation (2)  ·  Ain Shams University (1)  ·  Boston Children's Hospital (1)  ·  Future University in Egypt (1)  ·  Guang'anmen Hospital of China Academy of Chinese Medical Sciences (1)  ·  Hospital de Clínicas Dr. Manuel Quintela (1)  ·  Janssen Korea, Ltd., Korea (1)  ·  Janssen Pharmaceutica (1)

Countries

Belgium (10)  ·  United Kingdom (6)  ·  Canada (5)  ·  United States (5)  ·  China (4)  ·  South Korea (4)  ·  Romania (3)  ·  Bangladesh (2)  ·  Czechia (2)  ·  Egypt (2)  ·  Germany (2)  ·  Netherlands (2)  ·  Poland (2)  ·  Sweden (2)  ·  Thailand (2)

Top investigators

Susannah E Murphy, DPhil (3)  ·  Harald Winter, M.D. (2)  ·  Lawrence Hookey (2)  ·  Marc Van Outryve, MD (2)  ·  Angharad de Cates, MRCPsych (1)  ·  Christopher N Andrews, MD, MSc (1)  ·  D O'Neill, MD (1)  ·  Darlene Brady (1)  ·  Eman Elmokadem, PhD (1)  ·  Ervin Toth, MD PhD (1)  ·  Fergal Donnellan, MD (1)  ·  Fernando Fornari (1)  ·  Georges Coremans, MD (1)

Results publications

PMID 34585675, PMID 39664231, PMID 24106924, PMID 24732867, PMID 24917940, PMID 25581251, PMID 21039673, PMID 23535761, PMID 12144586, PMID 12743445, PMID 18509121, PMID 18987031, PMID 19751247, PMID 20529205, PMID 21848574, PMID 23269861, PMID 23480216, PMID 23539257, PMID 25239590, PMID 25808103, PMID 25869393, PMID 26880227, PMID 27270968, PMID 27891230, PMID 30472681, PMID 33273258, PMID 33615630, PMID 35639621, PMID 37098409, PMID 37215389, PMID 39584139, PMID 41080507

NIH funding

2009 (2), D43TW009114 (1)